Globally, the hepatitis B virus is a major cause of mortality from infectious diseases. Around 250 million people suffer from chronic HBV infections, with the virus being responsible for over one ...
Automation-compatible, safe assay delivers same-day results to accelerate vaccine and therapeutic antibody development PHILADELPHIA, Oct. 14, 2025 /PRNewswire/ -- Integral Molecular, a leader in ...
Biomedical research faces a ubiquitous and fundamental challenge: Because the goal of the research is to improve human health, the human body is logically the best place to perform experiments.
The MarketWatch News Department was not involved in the creation of this content. Automation-compatible, safe assay delivers same-day results to accelerate vaccine and therapeutic antibody development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback